ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,326.30
-0.57%
S&P ASX All Technology
3,878.80
-0.45%
Brent Oil
73.42
0.46%
US Dollar vs AUD
1.5404
0.73%
Bitcoin
94,267.45
2.08%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Valerio Therapeutics (ALVIO) Share Price

Valerio Therapeutics

Valerio Therapeutics (ALVIO)

EU
0.0726
0.0006
( 0.83% )
Updated: 00:45:50
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
0.0726
Bid
0.0728
Offer
0.0772
Volume
69,539
0.0726 Day's Range 0.0815
0.065 52 Week Range 0.186
Market Cap
11.207M
Previous Close
0.072
Open
0.0726
Last Trade
94
@
0.0726
Last Trade Time
00:15:22
Financial Volume
-
VWAP
-
Average Volume (3m)
96,737
Shares Outstanding
154,364,273
Dividend Yield
-
PE Ratio
-9.71
Earnings Per Share (EPS)
-0.13
Revenue
4.45M
Net Profit
-20.34M

About Valerio Therapeutics

Sector
Medicinal Chems,botanicl Pds
Industry
Medicinal Chems,botanicl Pds
Website
valeriotx.com/
Headquarters
Paris, Paris, Fra
Founded
-
Valerio Therapeutics is listed in the Medicinal Chems,botanicl Pds sector of the Euronext with ticker ALVIO. The last closing price for Valerio Therapeutics was 0.07 €. Over the last year, Valerio Therapeutics shares have traded in a share price range of 0.065 € to 0.186 €.

Valerio Therapeutics currently has 154,364,273 shares in issue. The market capitalisation of Valerio Therapeutics is 11.11 € million. Valerio Therapeutics has a price to earnings ratio (PE ratio) of -9.71.

Ask ADVFN Intelligence (AI)

ALVIO Latest News

More News

Réunion du Conseil d'administration de Valerio Therapeutics S.A. du 13 novembre 2024

Regulatory News: Lors d’une réunion tenue le 13 novembre 2024, le Conseil d'administration de Valerio Therapeutics (“Valerio Therapeutics” or la “Société”) (Euronext Growth Paris : ALVIO) a...

15 November 2024
Business Wire

Valerio Therapeutics Acquires Emglev Therapeutics, a Single-Domain Antibody-Based Therapeutics Company

Valerio Therapeutics acquires Emglev Therapeutics, a single-domain antibody-based therapeutics company The transaction was completed on September 29, 2024, enabling the acquisition of Emglev’s...

30 September 2024
Business Wire

Half-Year Liquidity Contract Statement for Valerio Therapeutics

Regulatory News: Under the liquidity contract entered into between VALERIO THERAPEUTICS (Paris:ALVIO) and Kepler Cheuvreux, the following resources appeared on the liquidity account on June 30...

06 August 2024
Business Wire

Valerio Therapeutics : compte rendu de l’assemblée générale mixte du 4 juin 2024

Regulatory News: Valerio Therapeutics S.A. (Euronext Growth Paris : ALVIO), ci-après « Valerio Therapeutics » ou « la Société », société de biotechnologie au stade clinique spécialisée dans le...

05 June 2024
Business Wire

Valerio Therapeutics fait une mise à jour du développement clinique de son essai clinique de phase 1/2 VIO-01

Le premier niveau de dose, évaluant 3 patients de l'essai VIO-01-101, a été autorisé conformément aux recommandations du Comité d'examen clinique. Aucun événement indésirable cliniquement...

23 May 2024
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0059-7.515923566880.07850.08150.072678320.07708655DE
4-0.009-11.02941176470.08160.08710.072400090.08063843DE
12-0.0104-12.53012048190.0830.120.072967370.09158152DE
26-0.0374-340.110.1240.065825950.09573839DE
52-0.1134-60.96774193550.1860.1860.065836630.11340095DE
156-0.2004-73.40659340660.2730.3480.065810990.15802127DE
260-0.2004-73.40659340660.2730.3480.065810990.15802127DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
EMGDSEuromedis DS
0.02 €
(72.41%)
379
HYLHyloris Pharmaceuticals SA
5.22 €
(30.50%)
80.71k
GNROGeNeuro SA
0.0716 €
(15.11%)
10.5k
IPHInnate Pharma
1.628 €
(10.75%)
73.08k
ALUNTUniti
1.43 €
(10.00%)
102
ALCYBCybergun
0.0001 €
(-50.00%)
37.67M
ELIORElior Group
3.056 €
(-25.75%)
6.36M
MLAAHAmatheon Agri Holding NV
0.0115 €
(-23.33%)
52k
MLACTActivium Group
1.38 €
(-17.37%)
200
ALAGOEPango SA
0.088 €
(-16.98%)
9.36M
ALCYBCybergun
0.0001 €
(-50.00%)
37.67M
ALNEVNeovacs
0.0002 €
(0.00%)
21.36M
ATODSAtos SE
0.0044 €
(-10.20%)
12.56M
BCPBanco Comercial Portugues SA
0.441 €
(0.27%)
12.36M
ALAGOEPango SA
0.088 €
(-16.98%)
9.36M

Discussion

View Full Feed
HoldEm777 HoldEm777 3 minutes ago
T3 bid says they want to drop it.
VPER
mzasif mzasif 3 minutes ago
$BNCM .03 wow! 10Q results $8m in revenue, 97m in assets, 10m in float and 499m in O/S
BNCM
IronChefQuezon IronChefQuezon 3 minutes ago
Sell
APRU
Maria56 Maria56 3 minutes ago
So who holds Richard Lapoutre's shares now?
MONI
dstock07734 dstock07734 3 minutes ago
DD,

Truly amazing investigation! They should sticky this one. But I doubt they would.

Great honor to have you as a great comrade!
NWBO
csuck555 csuck555 3 minutes ago
Everyone needs to do their part and tell the world about this gem before it's too late to get on board. Post about it on message boards. Mention it on social media. Comment about it on YouTube.  Do something. 
ELTP
toncatmad toncatmad 4 minutes ago
Leave it to Dugar to make Yoga pants carbon negative. 
Still doesn't change the fact that FKA BioAmber shareholders lost their investment due to its liquidation back in 2018 but hey who doesn't love yoga pants. 

Cward16 Cward16 4 minutes ago
CEO been gone!
CBRF
JV44 JV44 4 minutes ago
Eventually yes. 🫡
MGON
peafunke peafunke 4 minutes ago
Guess no yield just yet.  Maybe today he releases the filing ?  The calculator did say yesterday but wondering if better and day delayed it by a day. Not sure 
TPTW
TheKid5 TheKid5 4 minutes ago
All further reports will show continuous improvements. More funding news coming. The future is bright
CLNV
georgie18 georgie18 4 minutes ago
GNPX...$1.27...NEWS...🥳...https://www.prnewswire.com/news-releases/genprex-signs-exclusive-license-to-additional-gene-therapy-technologies-with-the-university-of-michigan-for-the-treatment-of-lung-cancer-302311506.html
GNPX
Monksdream Monksdream 4 minutes ago
QSI HALTED ri
QSI
Canna_Business Canna_Business 4 minutes ago
The Maryland Department of Agriculture allows the use of neem oil on medical cannabis during the flowering phase, but this raises significant health and safety concerns. Neem oil, while widely recognized as an organic pesticide, can transform into hazardous compounds when exposed to high heat, such
MSOS
1vman 1vman 4 minutes ago
***** No !!! 🚽UBQU🚽 Does not have 5 million in revenues , point in fact financials are not very good

ENOUGH SAID HUZZAH🤪 !!!
UBQU
varjim varjim 4 minutes ago
https://www.otcmarkets.com/otcapi/company/financial-report/417149/content
VAYK
katiesdad7 katiesdad7 4 minutes ago
Someone dumping early. Still 20K on the ask. Not a good sign.
CBRF
stealofadeal stealofadeal 4 minutes ago
$GEVI We opened up strong here. Something is brewing!
GEVI
TheHappyVulcan TheHappyVulcan 4 minutes ago
Ah, yes. Shoot the messenger. I am an easy target. All I did here was to report facts. No fiction. Everyone who vetted Astra and HES prior to making the cash committment must all have been completely fooled at every turn .


Just as rich as calling the HES technology an over
ASRE
rdeano221 rdeano221 4 minutes ago
Halted up ! Yahoo!!
QSI
georgie18 georgie18 5 minutes ago
GNPX...$1.27...NEWS...🥳...https://www.prnewswire.com/news-releases/genprex-signs-exclusive-license-to-additional-gene-therapy-technologies-with-the-university-of-michigan-for-the-treatment-of-lung-cancer-302311506.html
GNPX
linkvest linkvest 5 minutes ago
RADR ... This stock should be in your portfolio... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175407637
RADR
Canna_Business Canna_Business 5 minutes ago
The Maryland Department of Agriculture allows the use of neem oil on medical cannabis during the flowering phase, but this raises significant health and safety concerns. Neem oil, while widely recognized as an organic pesticide, can transform into hazardous compounds when exposed to high heat, such
CURLF
TerraRyzing TerraRyzing 5 minutes ago
Well it is Pink Current again, so....
SAPX
georgie18 georgie18 5 minutes ago
GNPX...$1.27...NEWS...🥳...https://www.prnewswire.com/news-releases/genprex-signs-exclusive-license-to-additional-gene-therapy-technologies-with-the-university-of-michigan-for-the-treatment-of-lung-cancer-302311506.html
GNPX

Your Recent History

EU
ALVIO
Valerio Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved